Madrigal Pharmaceuticals, Inc. (MDGL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Company Developments - Madrigal has made significant progress since the beginning of the year, including new intellectual property (IP) and European Union (EU) approval [3] - The company has entered into a new licensing agreement, indicating active business development and strategic partnerships [3]